About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Multiple Sclerosis Clinical Trials in Chicago | 112 Studies

Clinical Trials Multiple SclerosisChicago

Multiple Sclerosis Clinical Trials in Chicago

Find 112 clinical trials for multiple sclerosis near Chicago, Illinois. Connect with research centers in your area.

All Multiple Sclerosis trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 101-112 of 112 trials

CompletedStudy of Oral Fampridine-SR in Multiple SclerosisTo assess the safety and efficacy of 10 milligram (mg) twice a day (b.i.d.) Fampridine-SR in patients diagnosed with multiple sclerosis (MS), in a double-blind…NCT00127530·Birmingham, Alabama and 33 others

Multiple Sclerosis Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedA Study Evaluating B Cell Levels In Infants Potentially Exposed To Ocrelizumab During PregnancyThis study will evaluate the potential placental transfer of ocrelizumab in pregnant women with clinically isolated syndrome (CIS) or multiple sclerosis (MS) \[in line with the…NCT04998812·San Francisco, California and 10 others

UnknownPhysiology of Interregional Connectivity in the Human BrainThe purpose of this study is to understand the physiology of connectivity between cortical regions in the human brain in healthy participants and in patients with white matter…NCT03723434·Chicago, Illinois

RecruitingUblituximab (Briumvi) for Early Forms of Relapsing Multiple SclerosisIn this prospective, open-label, single-arm, single-institution trial, the investigators will accomplish the following two aims: 1. study the safety and tolerability of…NCT07225361·Chicago, Illinois

Active not recruitingInvestigating the Impact of Sex Hormones in Multiple SclerosisEmerging evidence indicates that females with MS experience worsened symptoms during the luteal phase (post ovulation) of the menstrual cycle when progesterone levels rise and…NCT07081594·Chicago, Illinois

CompletedOpen-Label Extension Study to Evaluate the Safety, Tolerability and Activity of Oral Fampridine-SR in Patients With Multiple Sclerosis Who Participated in the MS-F204 TrialThe purpose of the study is to evaluate the safety, tolerability and activity of Fampridine-SR when administered for up to 36 additional months in patients who previously…NCT00649792·Phoenix, Arizona and 41 others

CompletedJC Virus Antibody Study of Participants With Relapsing Forms of MS Receiving Treatment With NatalizumabThe primary objective of this study is to demonstrate that the incidence of progressive multifocal Leukoencephalopathy (PML) in natalizumab-treated participants who do not have…NCT01070836·Birmingham, Alabama and 477 others

RecruitingExercise Rehabilitation Program in MS Who Use Wheelchairs as a Primary Mobility DeviceApproximately 50% of people with multiple sclerosis (MS) use a wheelchair within 30 years of the initial diagnosis.NCT06410261·Chicago, Illinois

CompletedSafety and Efficacy of AVP-923 in PBA Patients With ALS or MSObjectives of the study are to evaluate the safety, tolerability, and efficacy of two different doses of AVP-923 (capsules containing either 30 mg of dextromethorphan hydrobromide…NCT00573443·Phoenix, Arizona and 61 others

RecruitingHome Based Functional Balance Intervention for Multiple SclerosisThe study involves a two-arm, Phase 1, randomized controlled clinical trial designed to establish the feasibility and effects of a Functional Balance Intervention (FBI) on…NCT07355387·Chicago, Illinois

CompletedTreatment Interruption of NatalizumabThis is a randomized, rater blinded trial in patients who interrupt treatment with natalizumab with or without being treated with other immunomodulatory drugs, or continue…NCT01071083·Cullman, Alabama and 32 others

WithdrawnContinuous Positive Airway Pressure (CPAP) for Fatigue in Patients With Multiple Sclerosis (MS) and Obstructive Sleep Apnea (OSA)Fatigue is a symptom present in 76 to 92% of people with multiple sclerosis (MS).NCT01563900·Chicago, Illinois

PreviousPage 6 of 6

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia